Roeleveld, N., Zielhuis, G
As always, this is a research-level exploration and not a clinical protocol any human use must await rigorous trials and regulatory approval
10.1056/NEJMoa1901118 36 IacobellisG.MohseniM.BiancoS
Especially given Bloombergs recent reporting that the FDA is gearing up for a hiring spree
In the action in diabetes and vascular disease (ADVANCE) trial, a study involving 11,140 subjects with T2DM who were followed for a median duration of 4.4 years, a higher HR was associated with a significantly increased risk of all-cause mortality, cardiovascular death, and major cardiovascular events (death, nonfatal acute myocardial infarction [AMI] or nonfatal stroke) [39]
Supports overall wellness : It helps maintain healthy nerve cells and red blood cells